BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16777224)

  • 41. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder.
    Smedley D; Somers G; Venter D; Chow CW; Cooper C; Shipley J
    Genes Chromosomes Cancer; 1998 Jan; 21(1):70-3. PubMed ID: 9443043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
    Agerstam H; Lilljebjörn H; Lassen C; Swedin A; Richter J; Vandenberghe P; Johansson B; Fioretos T
    Genes Chromosomes Cancer; 2007 Jul; 46(7):635-43. PubMed ID: 17394134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.
    Sahin F; Sercan Z; Ertan Y; Ocakci S; Ay E; Vural F; Yuksel E; Tombuloglu M; Saydam G
    Hematology; 2007 Dec; 12(6):489-92. PubMed ID: 17852454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
    Kim SY; Kim JE; Park S; Kim HK
    Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [8p11 myeloproliferative syndrome cured by allogeneic hematopoietic stem cell transplantation: two case reports and literature review].
    Xu LP; Chen Y; Shi HX; Huang XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):993-6. PubMed ID: 24343089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 8p11 myeloproliferative syndrome in a 3-year-old child.
    Kuskonmaz B; Kafali C; Akcoren Z; Karabulut HG; Akalin I; Tuncer MA
    Leuk Res; 2008 Jan; 32(1):198-9. PubMed ID: 17555813
    [No Abstract]   [Full Text] [Related]  

  • 48. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review.
    Macdonald D; Aguiar RC; Mason PJ; Goldman JM; Cross NC
    Leukemia; 1995 Oct; 9(10):1628-30. PubMed ID: 7564500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A rare case of myeloproliferative disease with t(8;13)(p11;q12) associated with eosinophilia and lymphadenopathy].
    Tsyba NN; Turkina AG; Chelysheva EY; Nemchenko IS; Kovrigina AM; Obukhova TN; Urnova ES; Kuzmina LA; Savchenko VG
    Ter Arkh; 2016; 88(7):98-103. PubMed ID: 27459622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [8p11 myeloproliferative syndrome].
    Li F; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1073-7. PubMed ID: 23998615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3.
    Tzankov A; Sotlar K; Muhlematter D; Theocharides A; Went P; Jotterand M; Horny HP; Dirnhofer S
    J Clin Pathol; 2008 Aug; 61(8):958-61. PubMed ID: 18663058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Konishi Y; Kondo T; Nakao K; Asagoe K; Otsuka Y; Nishikori M; Hishizawa M; Yamashita K; Takaori-Kondo A
    Bone Marrow Transplant; 2019 Feb; 54(2):326-329. PubMed ID: 30087462
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.
    Ren M; Li X; Cowell JK
    Blood; 2009 Aug; 114(8):1576-84. PubMed ID: 19506298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.
    Disperati P; Ichim CV; Tkachuk D; Chun K; Schuh AC; Wells RA
    Leuk Res; 2006 Feb; 30(2):233-9. PubMed ID: 16046234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.